Share this article
Share this article
ResearchAndMarkets.com s offering.
This report provides reliable estimates and real-world forecasts for the In Vitro diagnostics industry for two decades.
In its latest report the analyst estimates the market for In Vitro diagnostic products, including instruments, reagents and associated supplies to be $83.3 billion dollars. This is a substantial increase over our 2019 estimates, with 9 billion dollars of revenue originating from molecular and antibody COVID-19 testing responsible for most of the growth. Other infectious diseases (particularly respiratory pathogens), advanced cancer IVDs and increasing used of critical care and hematology tests are among the factors for additional growth.